Lexicon Pharma (LXRX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.35 --0%
Financial Fact:
Consolidated net loss: -36.02M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Consolidated net loss: -36.02M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of $0.01, $0.10 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $28.86 million versus the consensus estimate of $6.49 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Texas Capital Securities Reiterates Buy Rating on Fermi (FRMI)
- Healthcare Triangle reports revenue of $9.19M in Q2 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
